Skip to main content

Your search for “antibody” returned 210 results

Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support

July 29, 2015

A new study by researchers at University of California, San Diego School of Medicine reveals a protein’s critical – and previously unknown – role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer. The finding offers a novel target for better treating…

Unraveling a Key Junction Underlying Muscle Contraction

July 31, 2024

Using powerful new visualization technologies, researchers have captured the first 3-D images of the structure of a key muscle receptor, providing new insights on how muscles develop across the animal kingdom and setting the stage for possible future treatments for muscular disorders.

How Ovarian Cancer Defies Immunotherapy

April 11, 2022

Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health, with collaborators, have further elucidated how ovarian cancer tumors defy immunotherapy, identifying new molecular targets that might boost immune response.

Aversion to Risk by R&D Managers May Hurt U.S. Economic Prospects

March 16, 2020

Research and Development (R&D) has long been key in the U.S.’s economic prospects and according to new research from the University of California San Diego, the country’s ability to maintain its competitive edge in this area largely depends on managers in R&D being less averse to risk.

Kawasaki Disease Rates Dropped During COVID-19 Pandemic

June 17, 2022

UC San Diego researchers report significant decrease in national cases of Kawasaki disease during COVID-19 pandemic; findings hint at origins of disease.

Study: Immunotherapy Better than Chemotherapy for Subtype of Head and Neck Cancer

November 30, 2018

A randomized clinical trial involving 97 medical centers in 20 countries, including Moores Cancer Center at UC San Diego Health, found that treating patients with head and neck cancer with the immunotherapy drug pembrolizumab is more effective and less toxic than standard chemotherapy.

Tested and Testing: UC San Diego Health Expands COVID-19 Diagnostics

April 6, 2020

UC San Diego Health makes measurable progress addressing COVID-19 testing shortage through multiple partnerships and rapidly growing in-house testing. Success has meant more testing for more patients, first responders and other health systems.

Old Drugs Find New Target For Treating Brain Tumor

November 18, 2011

Scientists at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center, in collaboration with colleagues in Boston and South Korea, say they have identified a novel gene mutation that causes at least one form of glioblastoma (GBM), the most common type of malignant…

Bacteria-Virus Arms Race Provides Rare Window into Rapid and Complex Evolution

November 9, 2023

Rather than a slow, gradual process as Darwin envisioned, biologists can now see how evolutionary changes unfold on accelerated timescales. Using an arms race between bacteria and viruses, researchers are documenting complex evolutionary processes in simple laboratory flasks in only three weeks.

UC San Diego Cancer Scientist Wins $3 Million Award

February 20, 2013

Napoleone Ferrara, MD, PhD, the molecular biologist credited with helping decipher how tumors grow and now senior deputy director for basic sciences at the University of California, San Diego Moores Cancer Center, was today named one of 11 recipients of the inaugural Breakthrough Prize in Life Sciences, which comes with…

Category navigation with Social links